Compare NTHI & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTHI | AOMR |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.5M | 224.3M |
| IPO Year | N/A | 2021 |
| Metric | NTHI | AOMR |
|---|---|---|
| Price | $10.19 | $8.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $11.13 |
| AVG Volume (30 Days) | 68.0K | ★ 131.8K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 14.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.73 |
| Revenue | $59,990.00 | ★ $34,705,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.56 |
| P/E Ratio | ★ N/A | $12.19 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.20 | $7.36 |
| 52 Week High | $25.00 | $10.88 |
| Indicator | NTHI | AOMR |
|---|---|---|
| Relative Strength Index (RSI) | 58.54 | 54.65 |
| Support Level | $8.63 | $8.67 |
| Resistance Level | $9.75 | $8.93 |
| Average True Range (ATR) | 0.88 | 0.14 |
| MACD | 0.23 | 0.05 |
| Stochastic Oscillator | 95.59 | 96.26 |
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.